David Hollander, CMO & Global Therapeutics Lead: Revance Therapeutics RVNC Sell · Filed 24/11/19

Trade details

Type: Insider sale
Amount: $16,296.36
Shares · price: 3,908 sh · $4.17 a share
Held after: 104,945 sh
Stock: Revance Therapeutics RVNC
Person: David HollanderCMO & Global Therapeutics Lead
Trade date: 24/11/18
Filed: 24/11/19
Days to filing: 1 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Revance Therapeutics trades, last 26 weeks

What else happened in Revance Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/19~24/12/18

David Hollander's recent trades

No other trades yet.